查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067599

血液透析和腹膜透析市場規模、佔有率和趨勢分析報告：按類型、產品類型、應用、地區和細分市場分類（2026-2033 年）

Hemodialysis And Peritoneal Dialysis Market Size, Share & Trends Analysis Report By Type, By Product, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

血液透析和腹膜透析市場概述

全球血液透析和腹膜透析市場預計在 2025 年達到 1,194.9 億美元，預計到 2033 年將達到 2,503.8 億美元。

從2026年到2033年，市場預計將以9.84%的複合年成長率成長。血液透析和腹膜透析的需求受到多種因素的驅動，包括急性腎損傷發病率上升、器官捐贈者短缺、移植手術的風險、技術進步以及領先企業推出先進產品和服務的努力。

任何損害腎功能的疾病都可能導致慢性腎臟病（CKD），並可能隨著時間的推移而發展為末期腎功能衰竭（ESRD）。 CKD盛行率的不斷上升預計將推動透析產品的需求成長。慢性腎臟病盛行率的上升正成為全球主要的健康問題，並顯著促進了血液透析和腹膜透析市場的成長。 CKD盛行率的上升主要受文明病（如糖尿病、高血壓和肥胖症）快速成長的影響，這些疾病也是腎臟損傷的主要原因。此外，由於CKD早期通常進展緩慢，幾乎沒有症狀，因此診斷常常被延誤，增加了患者發展為末期腎功能衰竭（ESRD）的風險，而ESRD患者最終需要透析治療。篩檢計畫的改進和公眾意識的提高正在幫助發現更多病例，從而導致確診患者數量的增加。環境因素，例如接觸有害物質和某些地區水質差，也是導致CKD病例增加的原因之一。

文明病負擔的日益加重是加速血液透析和腹膜透析市場擴張的主要因素，因為這些疾病與腎臟損傷甚至最終的腎衰竭密切相關。糖尿病和高血壓等疾病是慢性腎臟病的主要原因，因為長期高血糖和高血壓會逐漸損害腎功能。肥胖、缺乏運動、不健康飲食和吸煙的日益普遍進一步增加了腎臟併發症的風險，導致全球慢性腎臟病病例持續上升。根據國際糖尿病聯盟（IDF）2024年的報告，全球糖尿病負擔正在迅速加重，目前約有5.89億成年人患有糖尿病。預計到2050年，這一數字將達到8.53億，尤其值得注意的是，其中超過五分之四的患者（81%）居住在中低收入國家。

隨著這些文明病的患者病情進展至腎病變晚期，對血液透析和腹膜透析等腎臟替代療法的需求顯著增加。此外，這些疾病在年輕族群中發病年齡提前，導致透析依賴時間延長，增加了長期治療的需求。患者數量的增加推動了透析中心的擴張、家庭腹膜透析的普及以及透析耗材和設備的使用量增加。

由於透析設備的持續技術進步，血液透析和腹膜透析市場正在成長。這些進步提高了治療效率、患者舒適度和臨床療效。高通量透析器、攜帶式和穿戴式式血液透析機以及自動化腹膜透析（APD）系統等創新技術正在提高透析的便利性和可及性，尤其是在居家照護。先進的監測功能、即時數據追蹤以及與數位健康平台的整合正在改善患者管理並減少與長期透析相關的併發症。例如，領先的腎臟護理產品和服務提供者費森尤斯醫療股份公司（Fresenius Medical Care AG）在2025年發布了一項新研究，顯示血液透析濾過（HDF）正在改善患者的治療效果。該公司還強調了人工智慧（AI）創新在幫助臨床醫生基於數據更有效地管理患者方面所發揮的作用。

此外，生物相容性材料和防感染導管的研發提高了病人安全性，並降低了不利事件的風險。這些技術進步促進了血液透析和腹膜透析的普及，推動了居家照護的普及，並鼓勵醫療機構升級現有基礎設施，從而顯著促進了市場成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 血液透析和腹膜透析市場：變數、趨勢和範圍

  • 市場譜系展望
  • 採用率和成長前景圖
  • 產業價值鏈分析
  • 市場動態
  • 血液透析及腹膜透析市場分析工具

第4章：血液透析和腹膜透析市場：按類型分類的估算和趨勢分析

  • 定義和範圍
  • 按類型分類的市場佔有率，2025 年和 2033 年
  • 血液透析和腹膜透析市場：按類型分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
    • 血液透析
    • 腹膜透析

第5章：血液透析和腹膜透析市場：產品特定估算和趨勢分析

  • 定義和範圍
  • 按產品分類的市場佔有率，2025 年和 2033 年
  • 血液透析與腹膜透析市場：產品展望
  • 市場規模、預測與趨勢分析，2021-2033年
    • 裝置
    • 消耗品
    • 服務

第6章 血液透析和腹膜透析市場：按最終用途分類的估算和趨勢分析

  • 定義和範圍
  • 按最終用途分類的市場佔有率，2025 年和 2033 年
  • 血液透析和腹膜透析市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
    • 在家工作
    • 醫院基地

第7章：血液透析和腹膜透析市場：區域估算和趨勢分析（按類型、產品類型和應用分類）

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 區域市場佔有率和主要公司（2025 年）
  • 市場產品、預測及2021年至2033年趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司和競爭對手的分類
    • 創新者
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Key company market share analysis, 2025
    • BD
    • Baxter
    • B. Braun SE
    • Medtronic
    • Fresenius Medical Care AG
    • DaVita
    • Asahi Kasei Medical Co., Ltd.
    • Nipro Corp.
    • Nikkiso Co., Ltd.
    • Cantel Medical
    • Diaverum（M42）
    • vivISOL
Product Code: GVR-1-68038-771-1

Hemodialysis And Peritoneal Dialysis Market Summary

The global hemodialysis and peritoneal dialysis market size was estimated at USD 119.49 billion in 2025 and is projected to reach USD 250.38 billion by 2033, growing at a CAGR of 9.84% from 2026 to 2033. The demand for hemodialysis and peritoneal dialysis is driven by several factors, including the rising incidence of acute kidney injury, the scarcity of organ donors, the risks associated with transplants, technological advancements, and initiatives by leading players to introduce advanced products and services.

Any condition with reduced kidney function leads to chronic kidney disease, which may develop into End-Stage Renal Disease (ESRD) over a period. An increase in the prevalence of CKD is expected to boost demand for dialysis products. The rising prevalence of chronic kidney disease is becoming a major global health concern, significantly contributing to the growth of the hemodialysis and peritoneal dialysis market. CKD prevalence is expanding due to the rapid increase in lifestyle-related disorders such as diabetes, hypertension, and obesity, which are the leading causes of kidney damage. Moreover, CKD often progresses silently with minimal symptoms in its early stages, leading to late diagnosis and a higher likelihood of patients advancing to end-stage renal disease (ESRD), where dialysis becomes unavoidable. Improved screening programs and greater awareness are now identifying more cases, thereby expanding the pool of diagnosed patients. Environmental factors, including exposure to toxins and poor water quality in certain regions, are also contributing to the increase in CKD cases.

The growing burden of lifestyle-related diseases is a major factor accelerating the hemodialysis and peritoneal dialysis market, as these conditions are closely linked to kidney damage and eventual renal failure. Diseases such as Diabetes Mellitus and Hypertension are among the leading causes of chronic kidney disease, as prolonged high blood sugar levels and elevated blood pressure gradually impair kidney function over time. The increasing prevalence of obesity, physical inactivity, unhealthy diets, and smoking further exacerbates the risk of kidney complications, leading to a steady rise in CKD cases globally. According to the International Diabetes Federation in 2024, the global burden of Diabetes Mellitus is rapidly increasing, with approximately 589 million adults currently affected, a figure projected to reach 853 million by 2050, and notably, over 4 in 5 (81%) of these individuals residing in low- and middle-income countries.

As more patients with these lifestyle-related conditions progress to advanced stages of kidney disease, the demand for renal replacement therapies such as hemodialysis and peritoneal dialysis increases significantly. In addition, the earlier onset of these diseases in younger populations extends the duration of dialysis dependency, thereby increasing long-term treatment demand. This growing patient pool is driving the expansion of dialysis centers, greater adoption of home-based peritoneal dialysis, and increased use of dialysis consumables and equipment.

The hemodialysis and peritoneal dialysis market is growing due to continuous technological advancements in dialysis equipment, which are improving treatment efficiency, patient comfort, and clinical outcomes. Innovations such as high-flux dialyzers, portable and wearable hemodialysis machines, and automated peritoneal dialysis (APD) systems are making dialysis more convenient and accessible, especially for home-based care. Advanced monitoring features, real-time data tracking, and integration with digital health platforms enable better patient management and reduce complications associated with long-term dialysis. For instance, in 2025, Fresenius Medical Care AG, a leading provider of renal care products and services, is showcasing new research highlighting that hemodiafiltration (HDF) is linked to improved patient outcomes. The company is also emphasizing the role of artificial intelligence (AI) innovations in helping clinicians manage patients more effectively and in a data-driven way.

In addition, the development of biocompatible materials and infection-resistant catheters is enhancing patient safety and reducing the risk of adverse events. These technological improvements are encouraging higher adoption of both hemodialysis and peritoneal dialysis, supporting the shift toward home care settings, and prompting healthcare providers to upgrade existing infrastructure, thereby significantly contributing to market growth.

Global Hemodialysis And Peritoneal Dialysis Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemodialysis and peritoneal dialysis market report based on type, product, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Hemodialysis
    • Conventional hemodialysis
    • Short daily hemodialysis
    • Nocturnal hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Device
    • Machine
    • Dialyzer
    • Water treatment system
    • Others
  • Consumables
    • Bloodline
    • Concentrates
    • Catheters
    • Others
  • Service
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Home-Based
  • Hospital-Based
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. End-useEnd use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hemodialysis And Peritoneal Dialysis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of acute kidney injury (AKI) and associated chronic kidney diseases
      • 3.4.1.2. Increasing incidence and prevalence of ESRD
      • 3.4.1.3. Introduction to technologically advanced products
      • 3.4.1.4. Growing geriatric population
      • 3.4.1.5. Increase in number of diabetes patient
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Risk and complications associated with dialysis
      • 3.4.2.2. Issues with product approval & commercialization
    • 3.4.3. Market oppurtunity analysis
      • 3.4.3.1. Expansion of home hemodialysis (HHD) programs
      • 3.4.3.2. Increasing healthcare investments in emerging economies
      • 3.4.3.3. Rising adoption of biocompatible and high-flux dialyzers
      • 3.4.3.4. Growing preference for home-based peritoneal dialysis
      • 3.4.3.5. Increasing government initiatives and reimbursement support for renal care
    • 3.4.4. Market challnge analysis
      • 3.4.4.1. Limited patient awareness and acceptance of peritoneal dialysis in some regions
      • 3.4.4.2. Shortage of skilled nephrologists and trained dialysis technicians
  • 3.5. Hemodialysis And Peritoneal Dialysis Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Hemodialysis And Peritoneal Dialysis Market: Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Type Market Share, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Hemodialysis And Peritoneal Dialysis Market by Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.5.1. Hemodialysis
      • 4.5.1.1. Hemodialysis market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.2. Conventional
        • 4.5.1.2.1. Conventional market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.3. Short Daily Hemodialysis
        • 4.5.1.3.1. Short daily hemodialysis market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.4. Nocturnal Hemodialysis
        • 4.5.1.4.1. Nocturnal hemodialysis market estimates and forecast 2021 to 2033 (USD Million)
    • 4.5.2. Peritoneal Dialysis
      • 4.5.2.1. Peritoneal dialysis market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.2.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
        • 4.5.2.2.1. Continuous ambulatory peritoneal dialysis (CAPD) market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.2.3. Automated Peritoneal Dialysis (APD)
        • 4.5.2.3.1. Automated peritoneal dialysis (APD) market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Hemodialysis And Peritoneal Dialysis Market: Product Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Product Market Share, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Hemodialysis And Peritoneal Dialysis Market by Product Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.5.1. Device
      • 5.5.1.1. Device market estimates and forecast 2021 to 2033 (USD Million)
      • 5.5.1.2. Machine
        • 5.5.1.2.1. Machine market estimates and forecast 2021 to 2033 (USD Million)
      • 5.5.1.3. Dialyzers
        • 5.5.1.3.1. Dialyzers market estimates and forecast 2021 to 2033 (USD Million)
      • 5.5.1.4. Water Treatment System
        • 5.5.1.4.1. Water treatment system market estimates and forecast 2021 to 2033 (USD Million)
      • 5.5.1.5. Others
        • 5.5.1.5.1. Others market estimates and forecast 2021 to 2033 (USD Million)
    • 5.5.2. Consumables
      • 5.5.2.1. Consumables market estimates and forecast 2021 to 2033 (USD Million)
      • 5.5.2.2. Bloodlines
        • 5.5.2.2.1. Bloodlines market estimates and forecast 2021 to 2033 (USD Million)
      • 5.5.2.3. Concentrates
        • 5.5.2.3.1. Concentrates market estimates and forecast 2021 to 2033 (USD Million)
      • 5.5.2.4. Catheters
        • 5.5.2.4.1. Catheters market estimates and forecast 2021 to 2033 (USD Million)
      • 5.5.2.5. Others
        • 5.5.2.5.1. Others market estimates and forecast 2021 to 2033 (USD Million)
    • 5.5.3. Service
      • 5.5.3.1. Service market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Hemodialysis And Peritoneal Dialysis Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. End-use Market Share, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Hemodialysis And Peritoneal Dialysis Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.5.1. Home-Based
      • 6.5.1.1. Home-based market estimates and forecast 2021 to 2033 (USD Million)
    • 6.5.2. Hospital-Based
      • 6.5.2.1. Hospital-based market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Hemodialysis And Peritoneal Dialysis Market: Regional Estimates & Trend Analysis, by Type, Product, and End-use

  • 7.1. Regional market share analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2025
  • 7.5. Market Product, & Forecasts, and Trend Analysis, 2021 to 2033:
  • 7.6. North America
    • 7.6.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 7.6.3. Canada
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 7.6.4. Mexico
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 7.7. Europe
    • 7.7.1. UK
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. UK market estimates and forecasts, 2021 - 2033
    • 7.7.2. Germany
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Germany market estimates and forecasts, 2021 - 2033
    • 7.7.3. France
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. France market estimates and forecasts, 2021 - 2033
    • 7.7.4. Italy
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 7.7.5. Spain
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 7.7.6. Denmark
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 7.7.7. Sweden
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Competitive scenario
      • 7.7.7.3. Regulatory framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 7.7.8. Norway
      • 7.7.8.1. Key country dynamics
      • 7.7.8.2. Competitive scenario
      • 7.7.8.3. Regulatory framework
      • 7.7.8.4. Reimbursement scenario
      • 7.7.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 7.8. Asia Pacific
    • 7.8.1. Japan
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Japan market estimates and forecasts, 2021 - 2033
    • 7.8.2. India
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. India market estimates and forecasts, 2021 - 2033
    • 7.8.3. China
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. China market estimates and forecasts, 2021 - 2033
    • 7.8.4. South Korea
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. South Korea market estimates and forecasts, 2021 - 2033
    • 7.8.5. Australia
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Australia market estimates and forecasts, 2021 - 2033
    • 7.8.6. Thailand
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Competitive scenario
      • 7.8.6.3. Regulatory framework
      • 7.8.6.4. Reimbursement scenario
      • 7.8.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 7.9. Latin America
    • 7.9.1. Brazil
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 7.9.2. Argentina
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 7.10. MEA
    • 7.10.1. South Africa
      • 7.10.1.1. Key country dynamics
      • 7.10.1.2. Competitive scenario
      • 7.10.1.3. Regulatory framework
      • 7.10.1.4. Reimbursement scenario
      • 7.10.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 7.10.2. Saudi Arabia
      • 7.10.2.1. Key country dynamics
      • 7.10.2.2. Competitive scenario
      • 7.10.2.3. Regulatory framework
      • 7.10.2.4. Reimbursement scenario
      • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 7.10.3. UAE
      • 7.10.3.1. Key country dynamics
      • 7.10.3.2. Competitive scenario
      • 7.10.3.3. Regulatory framework
      • 7.10.3.4. Reimbursement scenario
      • 7.10.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 7.10.4. Kuwait
      • 7.10.4.1. Key country dynamics
      • 7.10.4.2. Competitive scenario
      • 7.10.4.3. Regulatory framework
      • 7.10.4.4. Reimbursement scenario
      • 7.10.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2025
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Baxter
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. B. Braun SE
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Medtronic
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Fresenius Medical Care AG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. DaVita
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Asahi Kasei Medical Co., Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Nipro Corp.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Nikkiso Co., Ltd.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Cantel Medical
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Diaverum (M42)
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. vivISOL
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global hemodialysis and peritoneal dialysis market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 5 Global hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 6 Global hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America hemodialysis and peritoneal dialysis market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 9 North America hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 10 North America hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 12 U.S. hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 13 U.S. hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Canada hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 15 Canada hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 16 Canada hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Mexico hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 18 Mexico hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 19 Mexico hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe hemodialysis and peritoneal dialysis market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 22 Europe hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 23 Europe hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 24 UK hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 25 UK hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 26 UK hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 28 Germany hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 29 Germany hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 30 France hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 31 France hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 32 France hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Italy hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 34 Italy hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 35 Italy hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Spain hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 37 Spain hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 38 Spain hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Denmark hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 40 Denmark hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 41 Denmark hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Sweden hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 43 Sweden hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 44 Sweden hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Norway hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 46 Norway hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 47 Norway hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific hemodialysis and peritoneal dialysis market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 52 China hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 53 China hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 54 China hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Japan hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 56 Japan hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 57 Japan hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 59 India hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 60 India hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Australia hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 62 Australia hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 63 Australia hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Thailand hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 65 Thailand hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 66 Thailand hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 67 South Korea hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 68 South Korea hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 69 South Korea hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Latin America hemodialysis and peritoneal dialysis market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 72 Latin America hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 73 Latin America hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Brazil hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 75 Brazil hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 76 Brazil hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Argentina hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 78 Argentina hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 79 Argentina hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa hemodialysis and peritoneal dialysis market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 84 South Africa hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 85 South Africa hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 86 South Africa hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 90 UAE hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 91 UAE hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 92 UAE hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait hemodialysis and peritoneal dialysis market, by type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait hemodialysis and peritoneal dialysis market, by product, 2021 - 2033 (USD Million)
  • Table 95 Kuwait hemodialysis and peritoneal dialysis market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Hemodialysis and peritoneal dialysis market, market segmentation
  • Fig. 7 Market driver relevance analysis (current & future impact)
  • Fig. 8 Market restraint relevance analysis (current & future impact)
  • Fig. 9 Market opportunity relevance analysis (current & future impact)
  • Fig. 10 Market challenge relevance analysis (current & future impact)
  • Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Regional marketplace: key takeaways
  • Fig. 14 Global hemodialysis and peritoneal dialysis market, for hemodialysis, 2021 - 2033 (USD million)
  • Fig. 15 Global hemodialysis and peritoneal dialysis market, for conventional, 2021 - 2033 (USD million)
  • Fig. 16 Global hemodialysis and peritoneal dialysis market, for short daily hemodialysis, 2021 - 2033 (USD million)
  • Fig. 17 Global hemodialysis and peritoneal dialysis market, for nocturnal hemodialysis, 2021 - 2033 (USD million)
  • Fig. 18 Global hemodialysis and peritoneal dialysis market, for peritoneal dialysis, 2021 - 2033 (USD million)
  • Fig. 19 Global hemodialysis and peritoneal dialysis market, for continuous ambulatory peritoneal dialysis (CAPD), 2021 - 2033 (USD million)
  • Fig. 20 Global hemodialysis and peritoneal dialysis market, for automated peritoneal dialysis (APD), 2021 - 2033 (USD million)
  • Fig. 21 Global hemodialysis and peritoneal dialysis market, for device, 2021 - 2033 (USD million)
  • Fig. 22 Global hemodialysis and peritoneal dialysis market, for machine, 2021 - 2033 (USD million)
  • Fig. 23 Global hemodialysis and peritoneal dialysis market, for dialyzers, 2021 - 2033 (USD million)
  • Fig. 24 Global hemodialysis and peritoneal dialysis market, for water treatment system, 2021 - 2033 (USD million)
  • Fig. 25 Global hemodialysis and peritoneal dialysis market, for others, 2021 - 2033 (USD million)
  • Fig. 26 Global hemodialysis and peritoneal dialysis market, for consumables, 2021 - 2033 (USD million)
  • Fig. 27 Global hemodialysis and peritoneal dialysis market, for bloodlines, 2021 - 2033 (USD million)
  • Fig. 28 Global hemodialysis and peritoneal dialysis market, for concentrates, 2021 - 2033 (USD million)
  • Fig. 29 Global hemodialysis and peritoneal dialysis market, for catheters, 2021 - 2033 (USD million)
  • Fig. 30 Global hemodialysis and peritoneal dialysis market, for others, 2021 - 2033 (USD million)
  • Fig. 31 Global hemodialysis and peritoneal dialysis market, for service, 2021 - 2033 (USD million)
  • Fig. 32 Global hemodialysis and peritoneal dialysis market, for home-based, 2021 - 2033 (USD million)
  • Fig. 33 Global hemodialysis and peritoneal dialysis market, for hospital-based, 2021 - 2033 (USD million)
  • Fig. 34 Regional outlook, 2025 & 2033
  • Fig. 35 North America hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 36 U.S. hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 37 Canada hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 38 Mexico hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 39 Europe hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 40 Germany hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 41 UK hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 42 France hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 43 Italy hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 44 Spain hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 45 Denmark hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 46 Sweden hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 47 Norway hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 48 Asia Pacific hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 49 Japan hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 50 China hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 51 India hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 52 Australia hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 53 South Korea hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 54 Thailand hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 55 Latin America hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 56 Brazil hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 57 Argentina hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 58 Middle East and Africa hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 59 South Africa hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 60 Saudi Arabia hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 61 UAE hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 62 Kuwait hemodialysis and peritoneal dialysis market, 2021 - 2033 (USD million)
  • Fig. 63 Market participant categorization
  • Fig. 64 Company market share analysis, 2025
  • Fig. 65 Market differentiators
  • Fig. 66 Competitive dashboard analysis
  • Fig. 67 Regional network map